Skip to content

Effects of Folic Acid Supplementation on Arsenic Lowering

Efficacy and Safety of Folic Acid Supplementation Lowering Arsenic in a Chronic, Low-level Exposed Arsenic Population: a Randomized, Double-blind, Placebo Controlled Clinical Trial.

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02235948
Enrollment
450
Registered
2014-09-10
Start date
2014-07-31
Completion date
2016-12-31
Last updated
2014-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arsenic Poisoning, Toxic Effect of Arsenic and Its Compounds

Keywords

arsenic induced health problem, modifying effects, folic acid, oxidative damage, clinical trial

Brief summary

The purpose of this study is to determine whether folic acid supplementation are effective on arsenic lowering in a chronic, low-level arsenic exposed population.

Detailed description

Outcome measure: Changes of arsenic metabolites at baseline and week 8 Methods High-performance liquid chromatography (HPLC)

Interventions

0.8mg folic acid/day

Sponsors

Wenzhou Medical University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men or women more than 18 years of age and chronically exposed to arsenic (arsenic concentration of the drinking water \>10ug/L); * Population who had no folic acid supplementation in the 2 weeks before the study; * Women of childbearing age agreed to use a reliable contraception method during the study; * Everyone volunteered to participate and signed informed consent.

Exclusion criteria

* Pregnant or breast-feeding women; * Allergic to folic acid; * Having clearly defined allergic history; * Reported long-term use of folic acid and other vitamins B; * Having obvious signs or laboratory abnormalities which could affect the efficacy of folic acid; * Unsuitable to participate in the study based on the judgment of the investigators; * Not agree to cancel the medications which may affect serum folate concentration during the study period; * Subjects who plan to become pregnant during the study or move out of the area within the study period;

Design outcomes

Primary

MeasureTime frame
Change of urine arsenic metabolites between baseline and week 8baseline, week 8

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026